TPPH Insider Trading Activity and SEC Form 4 Filings
TPPH insider trading summary
No open-market insider purchases or sales of Tapestry Pharmaceuticals, Inc (TPPH) have been reported on SEC Form 4 in the past 12 months.
Latest TPPH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 16, 2008 | Goldman Sachs & Co | 10% Owner | Sell | $570 (190,000 @ $0.00) |
| Oct 16, 2008 | Goldman Sachs Group Inc | 10% Owner | Sell | $570 (190,000 @ $0.00) |
| Oct 15, 2008 | Julian Baker | 10% Owner | Sell | $6 (5,573 @ $0.00) |
| Oct 15, 2008 | Felix Baker | 10% Owner | Sell | $2K (1,821,429 @ $0.00) |
| Oct 15, 2008 | Julian Baker | 10% Owner | Sell | $2K (1,821,429 @ $0.00) |
| Oct 15, 2008 | Felix Baker | 10% Owner | Sell | $112 (112,451 @ $0.00) |
| Oct 15, 2008 | 14159 capital (GP), LLC | 10% Owner | Sell | $112 (112,451 @ $0.00) |
| Oct 15, 2008 | Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | Sell | $2K (1,821,429 @ $0.00) |
| Oct 15, 2008 | Felix Baker | 10% Owner | Sell | $6 (5,573 @ $0.00) |
| Oct 15, 2008 | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | $6 (5,573 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.